Additionally, we found that recurrent tumors exhibited higher B7-H3 expression than primary tumors after treatment with postoperative adjuvant chemotherapy, suggesting that tumor B7-H3 was associated with resistance to adjuvant chemotherapy and acted as an independent prognostic factor, especially in high-risk COAD patients. This evidence concerns the gene CD276 and colon adenocarcinoma.